PTTG1IP and breast cancer: This is in accordance with the PTTG1IP expression data of the five predictable NR (Table 4) that showed significantly smaller transcript levels than the fastest R. These findings are in line with previous observations linking underexpression of PTTG1IP and a higher expression of Securin with a higher risk in breast cancer patients for a more aggressive progression.